The upcoming virtual emergency scientific consultation on Andes Virus medical countermeasures (MCM) R&D is a crucial gathering that will bring together a diverse range of experts to address the evolving Andes virus situation. This consultation, organized by the WHO Research & Development Blueprint for Epidemics and the Bunyavirus Collaborative Open Research Consortium (CORC) led by the United Kingdom Health Security Agency (UKHSA), is scheduled for May 15, 2026, from 13:00 to 16:00 Geneva time (CET).
The primary objective of this rapid consultation is to review the latest evidence and identify immediate priorities for coordinated research and MCM development. The Andes virus, a hantavirus, poses a significant public health concern, and this consultation aims to address the current epidemiological developments, transmission dynamics, and historical and recent evidence of human-to-human transmission. By gathering leading experts, researchers, clinicians, public health authorities, funders, and partners, the consultation will foster collaboration and knowledge-sharing to tackle this emerging threat.
The agenda for the consultation is comprehensive, covering critical areas such as:
- Current Epidemiological Developments and Transmission Dynamics: Understanding the latest trends and patterns in the virus's spread is essential for effective prevention and control measures.
- Historical and Recent Evidence on Human-to-Human Transmission: This section will delve into the scientific understanding of how the virus spreads between humans, which is crucial for developing targeted interventions.
- Clinical Management and Natural History Studies: Exploring the clinical management of infected individuals and studying the natural progression of the disease will inform treatment strategies and patient care.
- Diagnostics, Therapeutic, and Vaccine MCM Landscapes: This part of the consultation will focus on the current state of medical countermeasures, including diagnostics, therapeutics, and vaccine development, and identify gaps and priorities for future research.
The consultation's outcomes will be made available through presentations and recordings, ensuring that the scientific community and relevant stakeholders can access the valuable insights and recommendations generated during the event. This collaborative effort is a testament to the global commitment to addressing emerging infectious diseases and highlights the importance of rapid scientific consultation in public health emergency management.
